Unlock the power of bazedoxifene--a groundbreaking third-generation selective estrogen receptor modulator (SERM) tailored for menopausal relief and osteoporosis prevention. Its distinctive action not only alleviates hot flashes but also safeguards your endometrium and fortifies bone health.
Mechanism
Bazedoxifene's tissue-targeting prowess sets it apart. It acts as an estrogen agonist in bones, boosting density and minimizing fracture risk, while simultaneously blocking estrogen effects in the endometrium and breast, lowering the chances of hyperplasia and breast cancer. This selective approach makes it a standout choice over older SERMs.
Research
Robust clinical evidence from the SMART program highlights bazedoxifene's efficacy--cutting new vertebral fractures by 35-42% and maintaining endometrial safety with less than 1% hyperplasia incidence. When paired with conjugated estrogens, it provides substantial relief from moderate-to-severe hot flashes without increasing endometrial risks.
Synergies
Harnessing the 'Tissue Selective Estrogen Complex', the combination of bazedoxifene and conjugated estrogens maximizes hormone benefits while minimizing adverse effects. Join Ben IQ for personalized lab analysis to determine the best stacking options for your unique health journey.
Trade-Offs
Keep in mind that these are general considerations. Your unique health profile demands a tailored approach.